Ficlatuzumab (Anti-HGF / SF) | c-Met | Read Reviews & Product Use Citations

Ficlatuzumab (Anti-HGF / SF) is a monoclonal antibody (McAb) targeting human hepatocyte growth factor (HGF). It inhibits c-Met receptor-mediated cancer cell proliferation, migration, and invasion and can be used to treat head and neck squamous cell carcinoma (HNSCC). MW :150 KD.

Purity & Quality Control

≥99

Choose Selective c-Met Inhibitors

Biological Activity

Description	Ficlatuzumab (Anti-HGF / SF) is a monoclonal antibody (McAb) targeting human hepatocyte growth factor (HGF). It inhibits c-Met receptor-mediated cancer cell proliferation, migration, and invasion and can be used to treat head and neck squamous cell carcinoma (HNSCC). MW :150 KD.

References
[1] Kumar D, et al. JAMA Otolaryngol Head Neck Surg. 2015 Dec;141(12):1133-9.

References

[1] Kumar D, et al. JAMA Otolaryngol Head Neck Surg. 2015 Dec;141(12):1133-9.

Product Details

CAS No.	1174900-84-5
Molecular Weight	150
Isotype	Human IgG1
Source	CHO
Purification	AKTA
Sterility	0.2 μM filtered
Formulation	100mMPro-Ac,20mMArg-Ac，pH5.0
Storage (From the date of receipt)	Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field